Diese Veranstaltung hat bereits stattgefunden
Kongress5th Asia-Australia Congress on Controversies in Ophthalmology
Asia-Australia COPHy 2019200120 Shanghai Shi, China
Zum Kalender hinzufügen
-
Datum
21.02.2019, 19:00 - 23.02.2019, 18:00Veranstalter
ComtecmedKurzbeschreibung
We are pleased to announce and invite you to attend the 5th Annual Congress on Controversies Ophthalmology: Asia-Australia (COPHy AA) which will take place in, Shanghai, China, February 21-23, 2019. Topics will include the treatment of retinal diseases such as age-related macular degeneration and diabetic macular edema, the role of anti-VEGF agents versus panretinal photocoagulation in the management of proliferative diabetic retinopathy, polypoidal choroidal vasculopathy and more.Gebühren
Fachärzte
Teilnehmer max.
unbegrenzt
Gebühren ab
430,00 EURHinweis
EARLY REGISTRATION
Until Jan 10, 2019
Physicians and Scientists: € 430,00
Physicians and Scientists from surrounding countries**: € 300,00
LATE REGISTRATION
Jan 11 – Feb 12, 2019
Physicians and Scientists: € 520,00
Physicians and Scientists from surrounding countries**: € 365,00
ON-SITE
REGISTRATION
Feb 13, 2019 and On-Site
Physicians and Scientists: € 570,00
Physicians and Scientists from surrounding countries**: € 400,00
Daily Registration:
Chinese Physicians and Scientists: € 140,00
Full Registration: €190,00
** Surrounding countries include: Kora, Russia, Mongolia, Kazakhstan, Kyrgyzstan, Tajikistan, Afghanistan, Pakistan, India, Nepal, Bhutan, Myanmar, Laos and Vietnammedizinisches Fachpersonal
Teilnehmer max.
unbegrenzt
Gebühren ab
330,00 EUR
Earlybird bis 10.01.2019
-1,00 EUR
Hinweis
EARLY
REGISTRATION
Until Jan 10, 2019
Trainees*, Nurses: € 330,00
Trainees*, Nurses from surrounding countries**: € 230,00
LATE
REGISTRATION
Jan 11 – Feb 12, 2019
Trainees*, Nurses: € 400,00
Trainees*, Nurses from surrounding countries**: € 280,00
ON-SITE
REGISTRATION
Feb 13, 2019 and On-Site
Trainees*, Nurses: € 440,00
Trainees*, Nurses from surrounding countries**: € 310,00
Daily Registration:
Chinese Trainees* and Nurses: € 120,00**
* Must be accompanied by documents, under 35 years old.
** Surrounding countries include: Kora, Russia, Mongolia, Kazakhstan, Kyrgyzstan, Tajikistan, Afghanistan, Pakistan, India, Nepal, Bhutan, Myanmar, Laos and Vietnam
Studenten/-innen
Teilnehmer max.
unbegrenzt
Gebühren ab
330,00 EURHinweis
EARLY REGISTRATION
Until Jan 10, 2019
Students: € 330,00
Students from Surrounding Countries**: € 230,00
LATE
REGISTRATION
Jan 11 – Feb 12, 2019
Students: € 400,00
Students from Surrounding Countries**: € 280,00
ON-SITE
REGISTRATION
Feb 13, 2019 and On-Site
Students: € 440,00
Students from Surrounding Countries**: € 310,00
Daily Registration:
Chinese Students: € 120,00**
** Surrounding countries include: Kora, Russia, Mongolia, Kazakhstan, Kyrgyzstan, Tajikistan, Afghanistan, Pakistan, India, Nepal, Bhutan, Myanmar, Laos and Vietnam
Deadlines
Abstract
31.12.2018 Hinweis
-
RETINA FRIDAY, FEBRUARY 22, 2019
HALL A 08:30-10:00
OPENING SESSION | Big Controversies in Ophthalmology in 2019
Chairs:
Neil Bressler, USA 08:30-09:00
Debate I: Proliferative diabetic retinopathy: Five-year outcomes confirm anti-VEGF without PRP is an acceptable initial treatment
08:30-08:40
Yes: Susan Bressler, USA
08:40-08:50 No 08:50-09:00 Discussion 09:00-09:30
Debate II: Neuro-protection in glaucoma: A viable pursuit
09:00-09:10
Yes: Christopher Leung, Hong Kong
09:10-09:20 No 09:20-09:30 Discussion 09:30-10:00
Debate III: Atrophine should be used in children to prevent myopia
09:30-09:40
Yes: Tien Yin Wong, Singapore
09:40-09:50
No, not in all cases
09:50-10:00
Discussion 10:00-10:30 Visit to Exhibits - Coffee and Refreshment Break 10:30-12:00
RETINA I | Choroidal Neovascular Age-related Macular Degeneration
Chairs:
Xiaoxin Li, China; Adrian Koh, Singapore 10:30-11:00
Debate I: Treat and extend regimens are superior to PRN regimens
10:30-10:40
Yes: Gemmy Cheung, Singapore
10:40-10:50 No: Susan Bressler, USA 10:50-11:00 Discussion 11:00-11:30
Debate II: Large submacular hemorrhages typically should be managed initially with surgery, not anti-VEGF injections
11:00-11:10
Yes: Yaiji Sakamoto, Japan
11:10-11:20 No: Paisan Ruamviboonsuk, Thailand 11:20-11:30 Discussion 11:30-12:00
Debate III: New agents or delivery devices represents a clinically relevant advance in managing neovascular AMD
11:30-11:40
Yes: Jun Kong, China
11:40-11:50
No: Sherman Valero, Philippines
11:50-12:00
Discussion 12:00-12:15 Visit to Exhibits & Technical Break 12:15-13:15 INDUSTRY-SPONSORED LUNCHEON SYMPOSIUM (NOT FOR CME) 13:15-13:45 Visit to Exhibits - Dessert Break 13:45-15:15 RETINA II | Diabetic Macular Edema
Chairs: Xiaofeng Lin, China; Susan Bressler, USA 13:45:14:15 Debate I: Consider alternative treatment regimens for patients with suboptimal vision responses after first 3 intravitreal anti-VEGF injections 13:45-13:55
Yes: Michaella Goldstein, Israel 13:55-14:05
No: Voraporn Chikitmongkol, Thailand 14:05-14:15
Discussion 14:15-14:45 Debate II: For persistent DME after 6 injections, add focal/grid laser 14:15-14:25 Yes: Jun Kong, China 14:25-14:35 No: Timothy Lai, Hong Kong 14:35-14:45 Discussion 14:45-15:15 Debate III: Artificial intelligence is ready to be used widely for DR Screening 14:45-14:55 Yes 14:55-15:05 No: Daniel Ting, Singapore 15:05-15:15 Discussion 15:15-16:45 RETINA III| Retinal Detachment and Vitrectomy Chairs: Joseph Moisseiev, Israel; Taiji Sakamoto, Japan 15:15-15:45 Debate I: Non-clearing vitreous hemorrhage in PDR: Try a series of anti-VEGF injections before going to vitrectomy 15:15-15:25
Yes: Adrian Koh, Singapore 15:25-15:35
No: Taiji Sakamoto, Japan 15:35-15:45
Discussion 15:45-16:15 Debate II: Vitrectomy alone is superior to a scleral buckle for a total RD with small tear at 1 o'clock in a phakic 40-year old eye 15:45-15:55
Yes: Adiel Barak, Israel 15:55-16:05
No: Joseph Moisseiev, Israel 16:05-16:15
Discussion 16:15-16:45 Debate III: Attempt to treat focal vitreomacular traction with gas injection should be tried before considering vitrectomy 16:15-16:25 Yes: Shibo Tang, China 16:25-16:35 No: Adiel Barak, Israel 16:35-16:45 Discussion SATURDAY, FEBRUARY 23, 2019
HALL A 09:00-10:00
Vision Academy in Retina 2019
Chairs:
09:00-09:10 An introduction to Vision Academy 09:10-09:30
Debate I: A fellow eye to an eye with actively treated CMV would best be monitored by sophisticated home monitoring technology (PHP, Home OCT)
09:10-09:15
Yes
09:15-09:20 No 09:20-09:25 Presentation of viewpoint 09:25-09:30
Questions 09:30-09:50
Debate II: Futility of treatment: In some cases in which no improvement is anticipated treatment should be stopped
09:30-09:35
Yes
09:35-09:40 No 09:40-09:45
Presentation of viewpoint 09:45-09:50
Questions 09:50-10:00 Looking forward with the Vision Academy 10:00-10:30 Visit to Exhibits - Coffee and Refreshment Break 10:30-12:00 RETINA IV | Polypoidal Choroidal Vasculopathy
Chairs: Adrian Koh, Singapore; Won Ki Lee, South Korea 10:30-11:00 Debate I: EVEREST 2 and PLANET results should be compared 10:30-10:40
Yes: Won Ki Lee, South Korea 10:40-10:50 No: Adrian Koh, Singapore 10:50-11:00
Discussion 11:00-11:30 Debate II: ICG Angiography is needed to manage most cases of PCV 11:00-11:10
Yes
11:10-11:20 No: Voroporn Chaikitmongkol, Thailand
11:20-11:30 Discussion
11:30-12:00 Debate III: OCT-Angiography is useful in management of PCV 11:30-11:40
Yes: Gemmy Cheung, Singapore
11:40-11:50
No: Timothy Lai, Hong Kong
11:50-12:00
Discussion 12:00-12:15 Visit to Exhibition & Lunch Box Pick Up 12:15-13:15 INDUSTRY-SPONSORED LUNCHEON SYMPOSIUM (NOT FOR CME) 13:15-13:45 Visit to Exhibits - Dessert Break 13:45-15:15 RETINA V | Pathologic Myopia
Chairs: Hua Yan, China; Joseph Moisseiev, Israel 13:45:14:15 Debate I: Reduce children’s time indoors to reduce incidence of pathologic myopia 13:45-13:55
Yes 13:55-14:05
No 14:05-14:15
Discussion 14:15-14:45 Debate II: Macular hemorrhage without leakage on fluorescein or ICG angiography should be treated empirically with anti-VEGF therapy or PDT with verteporfin for possible choroidal neovascularization obscured by hemorrhage 14:15-14:25
Yes: Young Hee Yoon, South Korea 14:25-14:35
No: Shibo Tang, China 14:35-14:45
Discussion 14:45-15:15 Debate III: Myopic foveoschisis should be treated by vitrectomy 14:45-14:55
Yes: Joseph Moissieiv, Israel 14:55-15:05
No: Adiel Barak, Israel 15:05-15:15
Discussion 15:15-16:45 RETINA VI | Retinal Vein Occlusions
Chairs: Xiaoling Liang, China; Timothy Lai, Hong Kong 15:15-15:45 Debate I: Intravitreal steroids are a viable choice as first line therapy 15:15-15:25
Yes: Barry Kuppermann, USA 15:25-15:35
No: Gemmy Cheung, Singapore 15:35-15:45
Discussion 15:45-16:15 Debate II: SCORE 2 results: Choose aflibercept over bevacizumab for macular edema secondary to central retinal vein occlusion 15:45-15:55
Yes: Susan Bressler, USA 15:55-16:05
No: Young Hee Yoon, South Korea 16:05-16:15
Discussion 16:15-16:45 Debate III: Unilateral retinal vein occlusions in older individuals typically warrant work-up for systemic disease 16:15-16:25
Yes: Paisan Ruamviboonsuk, Thailand 16:25-16:35
No 16:35-16:45
Discussion 17:00-18:30 Think Tank: Controversies Across Ophthalmology
Chairs: Xiaxin Li, China; Tin Aung, Singapore; Paisan Ruamviboonsuk, Thailand 17:00-17:30 Debate I: Removal of cataract increases the risk of progression of macular degeneration 17:00-17:10
Yes: Barry Kuppermann, USA 17:10-17:20
No 17:20-17:30
Discussion 17:30-18:00 Debate II: Big data are the next big thing in ophthalmology 17:30-17:40
Yes: Daniel Ting, Singapore 17:40-17:50
No: Sherman Valero, Philippines 17:50-18:00
Discussion 18:00-18:30 Spirinolactone is effective as a treatment for CSR 18:00-18:10
Yes 18:10-18:20
No: Michaella Goldstein, Israel 18:20-18:30
Discussion GLAUCOMA
FRIDAY, FEBRUARY 22, 2019
HALL B 10:30-12:00 GLAUCOMA I | Screening and Monitoring Controversies
Chairs: Christopher Leung, Hong Kong 10:30-11:00 Debate I: MIGS is a passing fad 10:30-10:40
Yes
10:40-10:50
No: Christopher Leung, Hong Kong 10:50-11:00
Discussion 11:00-11:30 Debate II: Clear lens extraction is indicated for angle-closure glaucoma 11:00-11:10
Yes: Tin Aung, Singapore 11:10-11:20
No 11:20-11:30
Discussion 11:30-12:00 Debate III: Genetic profiling has a role in management of glaucoma 11:30-11:40
Yes 11:40-11:50
No 11:50-12:00
Discussion 12:00-12:15 Visit to Exhibition & Lunch Box Pick Up 12:15-13:15 INDUSTRY-SPONSORED LUNCHEON SYMPOSIUM (NOT FOR CME) 13:15-13:45 Visit to Exhibits - Dessert Break SATURDAY, FEBRUARY 23, 2019
HALL B 13:45-15:15 GLAUCOMA II | Management: Present and Future
Chairs: Ningli Wang, China; Ryo Asaoka, Japan 13:45:14:15 Debate I: Sustained release glaucoma systems will replace eye drops 13:45-13:55
Yes: Tin Aung, Singapore 13:55-14:05
No 14:05-14:15
Discussion 14:15-14:45 Debate II: Optic disc photography is outdated when we have OCT 14:15-14:25
Yes 14:25-14:35
No: Ryo Asaoka, Japan 14:35-14:45
Discussion 14:45-15:15 Debate III: Neuroprotective therapy for glaucoma will be available in the next 5 years 14:45-14:55
Yes: Christopher Leung, Hong Kong 14:55-15:05
No: Ryo Asaoka, Japan 15:05-15:10
Discussion ANTERIOR SEGMENT FRIDAY, FEBRUARY 22, 2019
HALL B 13:45-15:15 ANTERIOR SEGMENT I | Cataract
Chairs: Ehud Assia, Israel 13:45:14:15 Debate I: High myopia is best corrected by clear lens extraction 13:45-13:55
Yes 13:55-14:05
No: Ehud Assia, Israel 14:05-14:15
Discussion 14:15-14:45 Debate II: Suture fixation is better than intraocular fixation of IOL 14:15-14:25
Yes 14:25-14:35
No: Shaowei Li, China 14:35-14:45
Discussion 14:45-15:15 Debate III: Presbyopic correction should be considered in all cataract operations 14:45-14:55
Yes 14:55-15:05
No: Danying Zheng, China 15:05-15:10
Discussion SATURDAY, FEBRUARY 23, 2019
HALL B 14:00-15:30 ANTERIOR SEGMENT II | Cornea
Chairs: 15:15-15:45 Debate I: Toric IOLs should be used only in eyes with corneal regular astigmatism 15:15-15:25
Yes 15:25-15:35
No: Ehud Assia, Israel 15:35-15:45
Discussion 15:45-16:15 Debate II: DMEK typically is better than DSAEK 15:45-15:55
Yes 15:55-16:05
No 16:05-16:15
Discussion 16:15-16:45 Debate III: Laser refractive surgery: Lasik typically should be chosen over SMILE for up to -12 diopters 16:15-16:25
Yes 16:25-16:35 No 16:35-16:45
Discussion NEURO-OPHTHALMOLOGY FRIDAY, FEBRUARY 22, 2019
HALL B
15:15-16:45 NEURO-OPHTHALMOLOGY I | Afferent
Chairs: Andrew Lee, USA 15:15-15:45
Debate I: There is treatment for traumatic optic neuropathy
15:15-15:25
Yes 15:25-15:35
No: Andrew Lee, USA 15:35-15:45
Discussion 15:45-16:15
Debate II: There is treatment for non-arteritic anterior ischemic optic neuropathy (NAION) 15:45-15:55
Yes: Andrew Lee, USA 15:55-16:05
No 16:05-16:15
Discussion 16:15-16:45
Case Presentations
Moderator: Andrew Lee, USA
Panelist: All Speakers
SATURDAY, FEBRUARY 23, 2019
HALL B
10:30-12:00
NEURO-OPHTHALMOLOGY II | Efferent
Chairs: Andrew Lee, USA 10:30-11:00
Debate I: All patients with acute 6th nerve palsy should be imaged
10:30-10:40
Yes 10:40-10:50
No: Andrew Lee, USA 10:50-11:00
Discussion 11:00-11:30
Debate II: All patients with third nerve palsies should be imaged
11:00-11:10
Yes
11:10-11:20
No: Andrew Lee, USA 11:20-11:30
Discussion 11:30-12:00
Case Presentations
Moderator: Andrew Lee, USA
Panelist
12:00-12:15 Visit to Exhibition & Lunch Box Pick Up 12:15-13:15 INDUSTRY-SPONSORED LUNCHEON SYMPOSIUM (NOT FOR CME) 13:15-13:45 Visit to Exhibits - Dessert Break -
Venue Pudong Shangri-La 33 Fucheng Rd, LuJiaZui, Pudong Xinqu, Shanghai Shi, China, 200120
Comtecmed
53 Rothschild Boulevard
IL - 61000 Tel Aviv
Tel.: +972 (3) 566 6166
Fax: +972 (3) 566 6177 -
Registration required. For further information please contact the organizer.